The exhibition PHARMA had a surprisingly impressive collection of designed objects. As the majority of those materials were not seen by the public, it was a delight to see this work by some of the great designers of the 20th century. One element, while more politically oriented, that was not addressed is the lucrative side of the pharmaceutical industry, especially in the past 20 years. While the design of the marketing materials (at least those sent to physicians) has declined to a very rudimentary level, it would seem the effort once placed on design has been replaced by lucrative monetary incentives to prescribe medications. This, in my opinion, is the sad state of the majority of contemporary capitalistic corporations. However, as the PHARMA exhibit demonstrates, learning from the past allows the future to be shaped as to not repeat erroneous mistakes.
As Alvin Lustig is one of my favorite designers, seeing the work of his contemporaries was amazing. Will Burtin and Franco Grignani are two designers I had not heard of before and have since done research into their work. I am particularly fond of designs which use overlapping colors and shapes to elicit emotional responses towards a particular subject. I am also very fond of the swiss typography aesthetic which the majority of the designers. The combination of the swiss [read: structured] style and the modernist [read: playful] aesthetic can create, when executed well, beautiful compositions. Of which the majority of the work displayed exhibited. I was generally surprised by the overall effort placed in designing these marketing brochures. Contemporary corporations do not place such effort in to direct-to-physician marketing materials. I had assumed that was always the case as it is a very lucrative industry. However, seeing the timeline of the referenced companies and how they developed was, to say the least, eye-opening. It is not difficult to trace how the importance of brand perception (a result of the effort placed on design) was acknowledged and subsequently used to grow individual companies into the super-corporations they are today.
Regarding the future of design and the equivalent of the pharmaceutical industry, from my perspective, it is easy to assume that the financial corporations are the next dominant industry in relation to the role of graphic design. While the influence of these financial corporations on society are widely known [read: Lehman Brothers, Merrill Lynch, Bear Stearns], they're marketing materials, of which I receive a large amount, are terrible. Aside from Annual Reports, which at least consider design and composition, the majority of documentation sent out from Investment Banks, Hedge Funds, Quant. funds, are abysmal. As this industry, at least for the next decade or so, will continue to grow, so will the competition between them. Financial institutions will have to engage in creative marketing to garner new clients. Similar to the Pharmaceutical industry and the restrictions placed on them by the FDA, the Financial industry is currently dealing with restrictions on direct-to-consumer advertising by the SEC. If the SEC allows for an increase in advertising and soliciting by financial institutions, the demand for designers in this industry will grow rapidly.